2,6-Di-tert-Butyl-4-methylenecyclohexa-2,5-dien-1-one
- CAS
- 2607-52-5
- Formula
- C15H22O
- MW
- 218.33 g/mol
VQ-012897
Impurity reference standards
Everolimus impurities & reference standards
Characterised Everolimus impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
13reference materials
2isotope-labelled
COAHPLC · NMR · MS on request
42-O-tert-Butyldimethylsilyloxyethyl Rapamycin
- CAS
- 159351-68-5
- Formula
- C59H97NO14Si
- MW
- 1072.5 g/mol
VQ-030640
Rapamycin, 7-O-demethyl-42-O-(2-hydroxyethyl)-, (7ξ)
- CAS
- 408496-50-4
- Formula
- C52H81NO14
- MW
- 944.2 g/mol
VQ-048320
FAQs — Everolimus impurities
Which Everolimus impurities do you supply?
We list 13 Everolimus-related reference materials, including process impurities, degradation products, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Everolimus impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Everolimus impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Everolimus impurity standards
We reply within one business day with price, pack options, lead time and documentation.